TIG Advisors »

Protagonist Therapeutics shares owned by TIG Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by TIG Advisors from 13F filings

Historical chart of TIG Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by TIG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by TIG Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $873k 10k 87.34

More positions owned by TIG Advisors

Spdr Series Trust State Street Spd (SPYM)
Warner Bros Discovery Com Ser A Put Option (WBD)
Avidity Biosciences Ord
Cyberark Software SHS (CYBR)
Sealed Air
Frontier Communications Pare
EXACT Sciences Corporation
Hologic
Avadel Pharmaceuticals Com Shs (AVDL)
Electronic Arts (EA)
Ceridian Hcm Hldg
Clearwater Analytics Hldgs I Cl A Put Option (CWAN)
Norfolk Southern (NSC)
Sunococorp Com Shs Llc (SUNC)
Digitalbridge Group Cl A New (DBRG)

View all positions for TIG Advisors

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
Wellington Management Company
UBS Group
Johnson & Johnson
Invesco
Geode Capital Management
Woodline Partners
Perceptive Advisors
Citadel Advisors
Driehaus Capital Management
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics